Rahsaan Thompson

Insider Reports History

Location
233 Wilshire Boulevard, Suite 280, Santa Monica, CA
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Rahsaan W. Thompson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rahsaan Thompson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ZEVRA THERAPEUTICS, INC. Chief Legal & Compliance, Secretary Common Stock 42.7K $393K $9.21 Jun 26, 2025 Direct
ZEVRA THERAPEUTICS, INC. Chief Legal & Compliance, Secretary Restricted Stock Unit 133K $269K $7.92 Jun 21, 2025 Direct
Gritstone bio, Inc. EVP and General Counsel Common Stock 58.7K $112K $1.90 Jan 31, 2022 Direct
Lyell Immunopharma, Inc. Chief Legal Officer Option (right to buy) 245K Feb 24, 2023 Direct
Gritstone bio, Inc. EVP and General Counsel Stock Option (Right to Buy) 115K Jan 31, 2022 Direct
ZEVRA THERAPEUTICS, INC. Chief Legal & Compliance, Secretary Stock Option (right to buy) 68K Jan 30, 2025 Direct

Insider Reports Filed by Rahsaan Thompson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZVRA ZEVRA THERAPEUTICS, INC. Jun 26, 2025 1 -$221K 4 Jun 30, 2025 Chief Legal & Compliance, Secretary
ZVRA ZEVRA THERAPEUTICS, INC. Jun 21, 2025 2 $0 4 Jun 24, 2025 Chief Legal & Compliance, Secretary
ZVRA ZEVRA THERAPEUTICS, INC. Jan 30, 2025 2 $0 4 Feb 3, 2025 Chief Legal & Compliance, Secretary
ZVRA ZEVRA THERAPEUTICS, INC. Jun 21, 2024 1 $0 4 Jun 25, 2024 Chief Legal & Compliance, Secretary
ZVRA ZEVRA THERAPEUTICS, INC. Jun 21, 2024 0 $0 3 Jun 25, 2024 Chief Legal & Compliance, Secretary
LYEL Lyell Immunopharma, Inc. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Legal Officer
LYEL Lyell Immunopharma, Inc. Oct 10, 2022 1 $0 4 Oct 12, 2022 Chief Legal Officer
LYEL Lyell Immunopharma, Inc. Sep 28, 2022 0 $0 3 Oct 3, 2022 Chief Legal Officer
GRTS Gritstone bio, Inc. Jan 31, 2022 2 $0 4 Apr 20, 2022 EVP and General Counsel
GRTS Gritstone bio, Inc. Jan 7, 2021 1 $0 4 Nov 19, 2021 EVP and General Counsel